Measuring and mapping the global burden of antimicrobial resistance

BMC Medicine

Volumn 16, Issue 1, 2018, Pages

  Hay, Simon I ^a,b   Rao, Puja C ^a   Dolecek, Christiane ^b,c   Day, Nicholas P J ^b,c   Stergachis, Andy ^a   Lopez, Alan D ^b,d   Murray, Christopher J L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anti infective agents; Antimicrobial drugs; Antimicrobial resistance; Drug resistant infections; Global burden of disease; Global health; Microbial; Public health

Indexed keywords

AMIKACIN; CAPREOMYCIN; CARBAPENEM; CEPHALOSPORIN; CHLORAMPHENICOL; ISONIAZID; KANAMYCIN; METICILLIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM; DISEASE ASSESSMENT; GEOGRAPHIC DISTRIBUTION; GLOBAL DISEASE BURDEN; HUMAN; INCIDENCE; INFECTION; MORBIDITY; MORTALITY; NONHUMAN; NOTE; PREVALENCE; SEPSIS; COMMUNICABLE DISEASE; DRUG EFFECT; GLOBAL HEALTH;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; DRUG RESISTANCE, BACTERIAL; GLOBAL HEALTH; HUMANS;

EID: 85047964719     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-018-1073-z     Document Type: Note

References (17)

1. Chief Medical Officer Annual Report 2011. Antimicrobial Resistance - GOV.UK. https://www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2. Accessed 19 Mar 2018.
2. Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond Ser B Biol Sci. 2015;370:20140082.
3. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed 20 Mar 2018.
4. Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, Dinic M, Petrovic J, Randjelovic G, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther. 2016;41:532-7.
5. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901-4.
6. Cabello FC, Godfrey HP, Tomova A, Ivanova L, Dölz H, Millanao A, et al. Antimicrobial use in aquaculture re-examined: its relevance to antimicrobial resistance and to animal and human health. Environ Microbiol. 2013;15:1917-42.
7. Sharma C, Rokana N, Chandra M, Singh BP, Gulhane RD, Gill JPS, et al. Antimicrobial resistance: its surveillance, impact, and alternative management strategies in dairy animals. Front Vet Sci. 2017;4:237.
8. Woolhouse M, Ward M, van Bunnik B, Farrar J. Antimicrobial resistance in humans, livestock and the wider environment. Philos Trans R Soc B Biol Sci. 2015;370(1670):20140083.
9. Fletcher S. Understanding the contribution of environmental factors in the spread of antimicrobial resistance. Environ Health Prev Med. 2015;20:243-52.
10. Graetz N, Friedman J, Osgood-Zimmerman A, Burstein R, Biehl MH, Shields C, et al. Mapping local variation in educational attainment across Africa. Nature. 2018;555:48-53.
11. Osgood-Zimmerman A, Millear AI, Stubbs RW, Shields C, Pickering BV, Earl L, et al. Mapping child growth failure in Africa between 2000 and 2015. Nature. 2018;555:41-7.
12. World Health Organization. Global Antimicrobial Resistance Surveillance System: Manual for Early Implementation. Geneva: WHO; 2015.
13. van der Meer JWM, Fears R, Davies SC, ter Meulen V. Antimicrobial innovation: combining commitment, creativity and coherence. Nature Rev Drug Discov. 2014;13:709-10.
14. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151-210.
15. Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345-422.
16. Hay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1260-344.
17. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211-59.